Johnson & Johnson faces further probes in India
Personal care brand Johnson & Johnson faces further scrutiny over the safety of its baby shampoo and talcum powder products as the National Commission for Protection of Child Rights has questioned previous tests.
On Thursday, the NCPCR issued the Drug Controller General of India and its Central Drugs Standard Control Organisation with summons, the Press Trust of India reported. The NCPCR wishes to question what it believes are a lack of uniformity and standardisation in testing methods used to ascertain whether or not certain Johnson & Johnson products contained the carcinogenic substances formaldehyde and asbestos.
The NCPCR has asked the DCGI and CDSCO to present before it on March 12 documents and records to explain the standardised and validated method used for analysing Johnson & Johnson’s baby shampoo and talcum powder. The NCPCR has accused the CDSCO of a lack of diligence in its testing methods and information sharing.
“It is clear… that there is no uniformity in testing methods for the purpose of testing the presence of formaldehyde in baby shampoo and asbestos in talcum powder and the same is clearly a mandate of CDSCO to regulate,” said the NCPCR in a statement, the Press Trust of India reported.
Johnson & Johnson has faced inquiries in India and the U.S. concerning its baby shampoo and talcum powder products. In 2019, drug inspectors in Rajasthan stated they had discovered formaldehyde in two product batches of Johnson & Johnson’s 'No More Tears' baby shampoo which the business denied. The Kolkata-based Central Drugs Laboratory had also shared that it was safe to use the shampoo.
Copyright © 2021 FashionNetwork.com All rights reserved.